NEW YORK (GenomeWeb News) — Luminex and Exiqon have struck an agreement under which Exiqon will non-exclusively distribute a line of microRNA products the companies designed for Luminex’s xMAP platform in 2006.
The FlexmiR product line is based on Luminex’s xMAP technology and Exiqon’s locked nucleic acid technology.
The deal also gives Exiqon non-exclusive rights to sell Luminex systems worldwide.
Financial terms of the agreement were not released.
The companies claim FlexmiR can deliver more than 6,300 data points in four hours.